Antitumor Activity of a Monoclonal Antibody Directed Against Gastrin-Releasing Peptide in Patients With Small Cell Lung Cancer
- 1 July 1997
- Vol. 112 (1) , 256-261
- https://doi.org/10.1378/chest.112.1.256
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Biology of small cell lung cancerLung Cancer, 1995
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- Preclinical Evaluation of an Anti-Autocrine Growth Factor Monoclonal Antibody for Treatment of Patients With Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancera,bAnnals of the New York Academy of Sciences, 1988
- Gastrin-Releasing Peptide Gene-Associated Peptides Are Expressed in Normal Human Fetal Lung and Small Cell Lung Cancer: A Novel Peptide Family Found in Man*Journal of Clinical Endocrinology & Metabolism, 1988
- Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cellsBiochemical and Biophysical Research Communications, 1987
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980